The U.S. Food and Drug Administration ordered a hold on a study of an early-stage obesity drug being developed by Amgen, another potential setback in the company’s efforts to join the booming weight ...

Novo Nordisk (NVO), the maker of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe imposed ...

There is no record of Denmark announcing the tariff on Ozempic exports. The social media user who first shared the claim ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...